154 related articles for article (PubMed ID: 38246709)
1. Kikuchi-Fujimoto disease type lymph node reaction with increased plasmacytoid dendritic cells may appear as a side effect following COVID-19 vaccination: Report of a case and literature review.
Moreno de Juan G; Pérez Del Barrio A; Herrera Romero EG; González Ruiz M; Montes Moreno S
Rev Esp Patol; 2024; 57(1):42-47. PubMed ID: 38246709
[TBL] [Abstract][Full Text] [Related]
2. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
[TBL] [Abstract][Full Text] [Related]
3. Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance approach.
Rodríguez-Ferreras A; Maray I; Coya-Fernández C; Octavio-Bocigas MM; Fernández-Del Río MF; Casares-López S; Ruiz-Salazar J
Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):278-282. PubMed ID: 36458479
[No Abstract] [Full Text] [Related]
4. Kikuchi-Fujimoto-like lymphadenopathy following COVID-19 vaccine: diagnosis and management.
Betancur V; Net J; Chapman J; Yepes M
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36585044
[TBL] [Abstract][Full Text] [Related]
5. Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
Ikeda K; Kakehi E; Adachi S; Kotani K
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414349
[TBL] [Abstract][Full Text] [Related]
6. Kikuchi disease complicated with aseptic meningitis following COVID-19 Vaccination: a case report.
Kularathna MDSV; Medagama A; Bandara R; Yasarathna D; Dilani MKI; Anuththara T
J Med Case Rep; 2024 Jun; 18(1):270. PubMed ID: 38840233
[TBL] [Abstract][Full Text] [Related]
7. A rare encounter: Kikuchi-Fujimoto disease presenting atypically after BNT162b2 COVID-19 vaccination: a case report.
Nam KH; Choi Y
Scand J Rheumatol; 2023 Nov; 52(6):705-707. PubMed ID: 37606559
[No Abstract] [Full Text] [Related]
8. Fever with lymphadenopathy - Kikuchi Fujimoto disease, a great masquerader: a case report.
Dalugama C; Gawarammana IB
J Med Case Rep; 2017 Dec; 11(1):349. PubMed ID: 29246252
[TBL] [Abstract][Full Text] [Related]
9. Kikuchi-Fujimoto disease: a case report and the evaluation of diagnostic procedures.
Xu S; Sun W; Liu J
BMC Oral Health; 2019 Oct; 19(1):223. PubMed ID: 31638953
[TBL] [Abstract][Full Text] [Related]
10. Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination.
Caocci G; Fanni D; Porru M; Greco M; Nemolato S; Firinu D; Faa G; Scuteri A; La Nasa G
Haematologica; 2022 May; 107(5):1222-1225. PubMed ID: 34965702
[No Abstract] [Full Text] [Related]
11. Kikuchi-Fujimoto Disease Post COVID-19 Vaccination: Case Report and Review of Literature.
Tan HM; Hue SS; Wee A; See KC
Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835182
[TBL] [Abstract][Full Text] [Related]
12. Kikuchi-Fujimoto necrotizing lymphadenitis associated with cutaneous lupus erythematosus: a case report.
Lopez C; Oliver M; Olavarria R; Sarabia MA; Chopite M
Am J Dermatopathol; 2000 Aug; 22(4):328-33. PubMed ID: 10949458
[TBL] [Abstract][Full Text] [Related]
13. Kikuchi-Fujimoto Disease: a Case Report.
Aznab M; Kamalian N; Navabi J; Kavianimoghadam K
Acta Med Iran; 2015 Nov; 53(11):725-7. PubMed ID: 26786995
[TBL] [Abstract][Full Text] [Related]
14. Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) with atypical encephalitis and painful testitis: a case report.
Kido H; Kano O; Hamai A; Masuda H; Fuchinoue Y; Nemoto M; Arai C; Takeda T; Yamabe F; Tai T; Kasahara M; Suzuki K; Shiraga N; Sadamoto S; Wakayama M; Takahashi Y; Iwasaki Y; Shibuya K; Urita Y
BMC Neurol; 2017 Feb; 17(1):22. PubMed ID: 28143446
[TBL] [Abstract][Full Text] [Related]
15. Kikuchi-Fujimoto Diseasae: An Important Differential of Tuberculous Lymphadenitis.
Sultan S; Mushtaq H; Manan A
J Coll Physicians Surg Pak; 2020 Sep; 30(9):987-988. PubMed ID: 33036688
[TBL] [Abstract][Full Text] [Related]
16. Kikuchi-Fujimoto disease, a rare cause of lymphadenopathy in Africa. Description of the first case in Senegal and review of the literature.
Lame CA; Loum B; Fall AK; Cucherousset J; Ndiaye AR
Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Oct; 134(5):347-349. PubMed ID: 28279633
[TBL] [Abstract][Full Text] [Related]
17. The co-occurrence of Kikuchi-Fujimoto disease and systemic lupus erythematosus: a case report.
Yousefi M; Rukerd MRZ; Binafar H; Shoaie S; Mirkamali H; Pourzand P; Kaveh R
J Med Case Rep; 2023 Oct; 17(1):448. PubMed ID: 37884991
[TBL] [Abstract][Full Text] [Related]
18. Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.
Craig JW; Farinha P; Jiang A; Lytle A; Skinnider B; Slack GW
Am J Clin Pathol; 2023 Aug; 160(2):114-118. PubMed ID: 37526500
[TBL] [Abstract][Full Text] [Related]
19. [Necrotizing lymphadenitis (Kikuchi-Fujimoto disease) as a rare cause of cervical lymphadenopathies. Diagnosis and differential diagnosis].
Wüstenberg EG; Theissig F; Offergeld C; Hüttenbrink KB
Laryngorhinootologie; 2000 Feb; 79(2):93-5. PubMed ID: 10738716
[TBL] [Abstract][Full Text] [Related]
20. [Unidirectional axillary lymph node swelling in a 31-year-old woman].
Ziegler T; Robiller F; Schau A; Winkler C
Med Klin (Munich); 2002 Oct; 97(10):624-7. PubMed ID: 12386797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
